Mensa Binasukses is primarily engaged in pharmaceuticals activity. Its headquarters is located in Dki Jakarta. The company was founded in 1974. Mensa Binasukses, a prominent player in the Indonesian pharmaceutical industry, was founded by the visionary entrepreneur, Mr. Djoko Susanto. The company has established itself as a key provider of pharmaceutical products and healthcare solutions in Indonesia. Primarily, Mensa Binasukses focuses on the distribution and marketing of pharmaceutical products, while its secondary business lines include healthcare services and medical equipment distribution. The company operates a robust network of branches across major cities in Indonesia, ensuring a strong local geographical footprint. Mensa Binasukses offers a wide range of pharmaceutical products, including prescription medications, over-the-counter drugs, and health supplements. Some of its well-known product brands include Vitacimin and Konimex. Internationally, Mensa Binasukses has expanded its operations to several countries in Southeast Asia, enhancing its global geographical footprint. The company has formed strategic partnerships with leading global pharmaceutical companies to enhance its product offerings and market reach. As a member of various pharmaceutical and healthcare associations, Mensa Binasukses actively participates in industry forums and contributes to the development of healthcare standards in Indonesia. The company is committed to improving public health and well-being through its innovative products and services. Mensa Binasukses envisions becoming a leading healthcare provider in the region, driven by its mission to deliver high-quality pharmaceutical solutions and healthcare services to its customers.
Headquarters
Kawasan Industri Pulo Gadung
East Jakarta; Jakarta;
Postal Code: 13260
Contact Details: Purchase the PT Mensa Binasukses report to view the information.
Website: http://www.mbs.co.id
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service